Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Chemocentryx, Inc. (CCXI)  
$51.99 0.00 (0.00%) as of 4:30 Wed 10/19


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 69,210,000
Market Cap: 3.60(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $51.99 - $51.99
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   ChemoCentryx is an integrated biopharmaceutical company commercializing and developing new medications for inflammatory and autoimmune diseases and cancer. Co. targets the chemokine and chemoattractant systems to discover, develop and commercialize orally-administered therapies. In the U.S., Co. markets TAVNEOS® (avacopan) as an adjunctive treatment for adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis (ANCA-associated vasculitis), specifically granulomatosis with polyangiitis, and microscopic polyangiitis. Co. is also developing TAVNEOS for the treatment of severe Hidradenitis Suppurativa.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 217,623
Total Sell Value $0 $0 $0 $10,849,434
Total People Sold 0 0 0 4
Total Sell Transactions 0 0 0 6
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 472
  Page 5 of 19  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Vifor Fresenius Medical Care Renal Pharma Ltd. 10% Owner   –       –       •   2020-07-16 4 AS $56.03 $4,186,741 I/I (73,500) 9,817,325 -4%     
   Vifor Fresenius Medical Care Renal Pharma Ltd. 10% Owner   –       –       •   2020-07-15 4 AS $58.65 $5,110,971 I/I (86,298) 9,890,825 -6%     
   Vifor Fresenius Medical Care Renal Pharma Ltd. 10% Owner   –       –       •   2020-07-14 4 AS $56.91 $5,808,318 I/I (100,000) 9,977,123 -2%     
   Vifor Fresenius Medical Care Renal Pharma Ltd. 10% Owner   –       –       •   2020-07-08 4 AS $58.92 $5,994,745 I/I (100,000) 10,322,967 -3%     
   Vifor Fresenius Medical Care Renal Pharma Ltd. 10% Owner   –       –       •   2020-07-07 4 AS $57.72 $4,700,838 I/I (79,387) 10,422,967 1%     
   Vifor Fresenius Medical Care Renal Pharma Ltd. 10% Owner   –       –       •   2020-07-06 4 AS $57.80 $5,066,120 I/I (86,690) 10,502,354 2%     
   Vifor Fresenius Medical Care Renal Pharma Ltd. 10% Owner   –       –       •   2020-07-02 4 AS $56.47 $5,044,434 I/I (87,781) 10,589,044 0%     
   Schall Thomas J. President and CEO   •       •      –    2020-06-15 4 AS $65.04 $130,090 D/D (2,000) 2,268,557 -15%     
   Schall Thomas J. President and CEO   •       •      –    2020-06-15 4 OE $14.31 $28,620 D/D 2,000 2,270,557     -
   Cappel Markus J. Chief Bus. Officer & Treasurer   •       –      –    2020-06-12 4 AS $65.10 $2,183,519 D/D (33,541) 76,247 -10%     
   Cappel Markus J. Chief Bus. Officer & Treasurer   •       –      –    2020-06-12 4 OE $10.86 $364,255 D/D 33,541 109,788     -
   Schall Thomas J. President and CEO   •       •      –    2020-06-12 4 AS $65.08 $5,775,877 D/D (88,753) 2,268,557 -10%     
   Schall Thomas J. President and CEO   •       •      –    2020-06-12 4 OE $14.31 $1,270,055 D/D 88,753 2,357,310     -
   Kanaya Susan M EVP, CFO and Sec.   •       –      –    2020-06-12 4 AS $64.58 $3,229,035 D/D (50,000) 91,317 -10%     
   Kanaya Susan M EVP, CFO and Sec.   •       –      –    2020-06-12 4 OE $8.19 $466,100 D/D 50,000 141,317     -
   Kanaya Susan M EVP, CFO and Sec.   •       –      –    2020-06-03 4 OE $3.57 $57,059 I/I 10,750 104,930     -
   Cappel Markus J. Chief Bus. Officer & Treasurer   •       –      –    2020-05-26 4 AS $60.34 $1,183,423 D/D (19,612) 76,247 -1%     
   Cappel Markus J. Chief Bus. Officer & Treasurer   •       –      –    2020-05-26 4 OE $6.62 $129,831 D/D 19,612 95,859     -
   Parker Geoffrey M. Director   –       •      –    2020-05-23 4 OE $0.00 $0 D/D 7,724 111,913     -
   Tyree James L Director   –       •      –    2020-05-23 4 OE $0.00 $0 D/D 7,724 13,069     -
   Cappel Markus J. Chief Bus. Officer & Treasurer   •       –      –    2020-05-22 4 AS $60.06 $2,454,525 D/D (40,867) 76,247 -1%     
   Cappel Markus J. Chief Bus. Officer & Treasurer   •       –      –    2020-05-22 4 OE $6.62 $270,540 D/D 40,867 117,114     -
   Edwards Thomas A. Director   –       •      –    2020-05-21 4 A $0.00 $0 D/D 4,660 166,357     -
   Feczko Joseph M Director   –       •      –    2020-05-21 4 A $0.00 $0 D/D 4,660 102,901     -
   Mckinnell Henry A Director   –       •      –    2020-05-21 4 A $0.00 $0 D/D 4,660 65,023     -

  472 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 5 of 19
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed